Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2450.00
  • There is currently no data for FDP

Issue of Equity

10 Feb 2014 07:00

RNS Number : 6237Z
First Derivatives PLC
10 February 2014
 

 10th February 2014

 

First Derivatives plc

("First Derivatives" or the "Company")

 

Dealing by Director

Exercise of Options

 

First Derivatives (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services to the capital markets industry, is pleased to announce that, following the exercise of options by a Director and certain employees, 179,167 new ordinary shares of 0.5p each in the Company have been issued and allotted.

 

Accordingly, application has been made for the 179,167 new ordinary shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 13th February 2014.

 

This includes options over 10,000 new ordinary shares exercised by Mr David Anderson, a Non-Executive Director, at a price of 178.5 pence per ordinary share.

 

Following this transaction Mr Anderson retains a holding of 142,500 First Derivatives ordinary shares representing approximately 0.73 per cent. of the issued share capital of the Company. Mr Anderson also has a beneficial interest in share options over 50,000 First Derivatives ordinary shares which represent approximately 0.25 per cent. of the issued share capital of the Company.

 

The new ordinary shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 19,485,988 ordinary shares.

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive Officer

www.firstderivatives.com

Graham Ferguson, Finance Director

Charles Stanley Securities

+44 (0)20 7149 6000

(Nominated Adviser& Broker)

Russell Cook

Carl Holmes

GoodbodyCorporate Finance

+353 1 667 0420

(ESM Adviser)

Finbarr Griffin

Goodbody Stockbrokers

Linda Hickey

 

Walbrook PR

+44 (0)20 7933 8780

Financial PR

bob.huxford@walbrookpr.com

Bob Huxford

helen.westaway@walbrookpr.com

Helen Westaway

 

About First Derivatives

 

First Derivatives is a global provider of software and consulting services to the financial services industry. With almost 17 years' experience working with leading financial institutions, it continues to deliver technologically advanced products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 850 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQKODPABKDQBK
Date   Source Headline
2nd Oct 20237:00 amRNSNotice of Results
31st Aug 20239:18 amRNSTotal Voting Rights
15th Aug 20237:00 amRNSIssue of Equity
31st Jul 20231:59 pmRNSTotal Voting Rights
20th Jul 20233:30 pmRNSResult of AGM
28th Jun 20234:17 pmRNSPDMR Notice and Issue of Equity
27th Jun 20234:30 pmRNSNotice of AGM
5th Jun 202312:43 pmRNSHolding(s) in Company
30th May 20231:01 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResults for the year ended 28 February 2023
18th May 20237:00 amRNSKX partnering with Amazon Web Services
5th Apr 20237:00 amRNSLTIP Award
4th Apr 20231:51 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSFY23 trading update
20th Mar 20237:00 amRNSGeneral availability of kdb Insights Enterprise
28th Feb 20238:39 amRNSTotal Voting Rights
13th Feb 20234:43 pmRNSIssue of Equity
30th Dec 202210:06 amRNSTotal Voting Rights
22nd Dec 20224:15 pmRNSHolding(s) in Company
20th Dec 20224:02 pmRNSIssue of Equity
14th Dec 20222:01 pmRNSHolding(s) in Company
30th Nov 20228:47 amRNSTotal Voting Rights
15th Nov 20227:00 amRNSIssue of Equity
31st Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Oct 202211:38 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSResults for the six months ended 31 August 2022
6th Oct 20222:02 pmRNSHolding(s) in Company
22nd Sep 20228:06 amRNSHolding(s) in Company
7th Sep 20227:00 amRNSNotice of Results
31st Aug 202210:09 amRNSTotal Voting Rights
16th Aug 20225:50 pmRNSIssue of Equity
5th Aug 20227:00 amRNSAppointment of Ashok Reddy as CEO of KX
2nd Aug 20229:49 amRNSHolding(s) in Company
29th Jul 202210:43 amRNSTotal Voting Rights
19th Jul 20227:00 amRNSIssue of Equity
7th Jul 20223:24 pmRNSResult of AGM
30th Jun 202212:30 pmRNSTotal Voting Rights
23rd Jun 20226:01 pmRNSIssue of Equity
8th Jun 20223:43 pmRNSNotice of AGM
31st May 202210:18 amRNSTotal Voting Rights
23rd May 20226:31 pmRNSRNS PDMR notice Issue of Equity
10th May 20227:00 amRNSResults for the year ended 28 February 2022
3rd May 20223:00 pmRNSHolding(s) in Company
26th Apr 20226:17 pmRNSHolding(s) in Company
11th Apr 20226:28 pmRNSTR1 - Notification of Major Holdings
6th Apr 20227:00 amRNSTrading update
5th Apr 20227:00 amRNSHolding(s) in Company
1st Mar 20227:00 amRNSKX Strategic Partnership Agreement with Microsoft
28th Feb 20225:52 pmRNSIssue of Equity
3rd Feb 20221:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.